ISG15/ISGylation in central nervous system diseases: molecular mechanisms and therapeutic targeting
Molecular Mechanisms of ISG15/ISGylation ISG15, or interferon-stimulated gene 15, is a small ubiquitin-like modifier that plays a crucial role in […]
Comparative Analysis of Mouse CSF Proteins in Experimental Autoimmune Encephalomyelitis Model and Cuprizone-Induced Demyelination Model by Olink Proteomics
Study Overview This research investigates protein alterations in the cerebrospinal fluid (CSF) using two distinct models of demyelination: Experimental Autoimmune
Microbiota and Guillain-Barré syndrome: role of microbial metabolites, biomarkers, and emerging therapeutic strategies
Microbial Metabolites and Their Role Recent studies have increasingly focused on the influence of microbial metabolites on human health, particularly
Diagnostic and therapeutic challenges in anti-NMDA receptor encephalitis associated with an ovarian immature teratoma
Pathophysiology of Anti-NMDA Receptor Encephalitis The condition known as anti-NMDA receptor encephalitis is regarded as a novel autoimmune encephalopathy, where
MicroRNA-mRNA Regulatory Network Associated with Cognitive Impairment in Multiple Sclerosis
MicroRNA-MRNA Interaction Dynamics MicroRNAs (miRNAs) are short, non-coding RNA molecules that play a crucial role in gene regulation by interacting
Dynamic metabolic programming of monocyte-derived cells defines immunity in CNS disease
Metabolic Programming in Monocyte-Derived Cells Monocyte-derived cells, particularly macrophages and dendritic cells, undergo a process termed metabolic programming, which significantly
Dynamic metabolic programming of monocyte-derived cells defines immunity in CNS disease Read Post »
Identification of Alzheimer’s disease subtypes and biomarkers from human multi-omics data using subspace merging algorithm
Study Overview The research focuses on enhancing our understanding of Alzheimer’s disease through the identification of its subtypes and biomarkers
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond
Biomarker Significance in Multiple Sclerosis Biomarkers have emerged as critical tools in the understanding and management of multiple sclerosis (MS),
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond
Emerging Biomarkers in MS Recent advancements in the understanding of multiple sclerosis (MS) have led to the identification of new
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond
Biomarker Significance in Multiple Sclerosis Biomarkers are critical in enhancing our understanding of multiple sclerosis (MS), a complex neurological disorder